Do you want to read an article? Please log in or register.
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
Further Publications
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)